Piper Sandler analyst Paul Newsome lowered the firm’s price target on Accelerant (ARX) to $13 from $18 and keeps an Overweight rating on the shares. The firm is revising its price targets on certain insurance brokers given the recent selloff where it remains relatively cautious.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARX: